Durability of Stavudine, Lamivudine and Nevirapine among Advanced HIV-1 Infected Patients with/without Prior Co-administration of Rifampicin: A 144-week Prospective Study

BACKGROUND: To date, data on the durability of a regimen of stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited settings. METHODS: A prospective cohort study was conducted among 140 antiretroviral-naïve patients who were enrolled to initiate d4T, 3TC and NVP...

Descripción completa

Detalles Bibliográficos
Autores principales: Manosuthi, Weerawat, Tantanathip, Preecha, Prasithisirikul, Wisit, Likanonsakul, Sirirat, Sungkanuparph, Somnuek
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577100/
https://www.ncbi.nlm.nih.gov/pubmed/18851761
http://dx.doi.org/10.1186/1471-2334-8-136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577100/
https://www.ncbi.nlm.nih.gov/pubmed/18851761
http://dx.doi.org/10.1186/1471-2334-8-136

Ejemplares similares